Table 3.
Characteristics of patients who received a deceased donor transplant
| Transplanted population N = 2747 |
White n = 995 (36.2%) |
Hispanic n = 849 (30.9%) |
Black N = 903 (32.9%) |
p-Value | |
|---|---|---|---|---|---|
| Patient level characteristics | |||||
| Age, mean ± SD | 14.8 ± 6.0 | 14.4 ± 6.1 | 14.1 ± 5.9 | 16.0 ± 5.7 | <0.001 |
| Age at transplant category, N (%), years | <0.001 | ||||
| < 1 year | 2 (0.1%) | 1 (0.1%) | 1 (0.1%) | 0 (0%) | |
| 1–5 years | 278 (10.1%) | 116 (11.7%) | 101 (11.9%) | 61 (6.7%) | |
| 6–10 years | 320 (11.7%) | 131 (13.2%) | 114 (13.4%) | 75 (8.3%) | |
| 11–17 years | 1269 (46.2%) | 434 (43.6%) | 409 (48.2%) | 426 (47.2%) | |
| 18–20 years | 392 (14.3%) | 143 (14.4%) | 114 (13.4%) | 135 (15.0%) | |
| 21–29 years | 486 (17.7%) | 170 (17.1%) | 110 (13.0%) | 206 (22.8%) | |
| Female, N (%) | 1222 (44.5%) | 456 (45.8%) | 380 (44.8%) | 386 (42.8%) | 0.395 |
| Health insurance coverage at time of ESRD start, N (%) | <0.001 | ||||
| Public | 1350 (49.1%) | 388 (39.0%) | 464 (54.7%) | 498 (55.2%) | |
| Private | 784 (28.5%) | 401 (40.3%) | 150 (17.7%) | 233 (25.8%) | |
| Other | 380 (13.8%) | 144 (14.5%) | 135 (15.9%) | 101 (11.2%) | |
| None | 233 (8.5%) | 62 (6.2%) | 100 (11.8%) | 71 (7.9%) | |
| Share 35 era | 573 (20.9%) | 194 (19.5%) | 222 (26.2%) | 157 (17.4%) | <0.001 |
| Pre-emptive waitlist | 300 (10.9%) | 152 (15.3%) | 59 (7.0%) | 89 (9.9%) | <0.001 |
| Inactive waitlist | 145 (5.3%) | 65 (6.5%) | 31 (3.7%) | 49 (5.4%) | 0.022 |
| Clinical and laboratory measures | |||||
| BMI > 85% | 305 (11.1%) | 95 (9.6%) | 63 (7.4%) | 147 (16.3%) | <0.001 |
| Peak panel reactive antibody at time of listing, N (%) | 0.057 | ||||
| 0% | 1897 (69.1%) | 692 (69.6%) | 598 (70.4%) | 607 (67.2%) | |
| 1–20% | 555 (20.2%) | 204 (20.5%) | 159 (18.7%) | 192 (21.3%) | |
| >20% | 220 (8.0%) | 67 (6.7%) | 65 (7.7%) | 88 (9.8%) | |
| Missing | 75 (2.7%) | 32 (3.2%) | 27 (3.2%) | 16 (1.8%) | |
| ABO blood group, N (%) | <0.001 | ||||
| A | 885 (32.2%) | 380 (28.6%) | 243 (28.6%) | 262 (29.0%) | |
| B | 340 (12.4%) | 94 (9.5%) | 79 (9.3%) | 167 (18.5%) | |
| AB | 88 (3.2%) | 37 (3.7%) | 22 (2.6%) | 29 (3.2%) | |
| O | 1431 (52.1%) | 483 (48.5%) | 503 (59.3%) | 445 (49.3%) | |
| Zip code-level characteristics for patient residence at ESRD start | |||||
| Neighborhood poverty (% zip below poverty), N (%) | <0.001 | ||||
| 0–4.9% | 271 (9.9%) | 191 (19.2%) | 25 (2.9%) | 55 (6.1%) | |
| 5–9.9% | 654 (23.8%) | 345 (34.7%) | 140 (16.5%) | 169 (18.7%) | |
| 10–14.9% | 530 (19.3%) | 216 (21.7%) | 144 (17.0%) | 170 (18.8%) | |
| 15–19.9% | 432 (15.7%) | 136 (13.7%) | 167 (19.7%) | 129 (14.3%) | |
| >20% | 860 (31.3%) | 107 (10.8%) | 373 (43.9%) | 380 (42.1%) | |